Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to Robert Griffin

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Griffin, Robert

Item TypeName
Academic Article Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.
Academic Article Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy.
Academic Article Cytotoxicity of perillyl alcohol against cancer cells is potentiated by hyperthermia.
Academic Article Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.
Academic Article Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy.
Academic Article Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.
Academic Article Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy.
Academic Article Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone.
Academic Article Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics.
Concept Antineoplastic Agents
Academic Article Modulation of dietary methionine intake elicits potent, yet distinct, anticancer effects on primary versus metastatic tumors.
Academic Article Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer.
Academic Article Acquired Radiation Resistance Induces Thiol-dependent Cisplatin Cross-resistance.

Search Criteria
  • Antineoplastic Agents